About: access to medicine
EU cooperation key for rare diseases research, accessible treatment, says expert
France is "ahead of the curve" when it comes to treating rare diseases, but with 36 million Europeans affected, cooperation at the EU level to advance research and make treatments more accessible is essential, an expert warned. EURACTIV France reports.OpinionPromoted content
More transparency in the pharmaceutical market can increase the affordability of medicines without comprising investments in R&D
To mark World Cancer Day, researchers from The Netherlands Cancer Institute and the University of Amsterdam publish results of the world’s first laboratory experiment on pharmaceutical transparency, showing that comprehensive transparency can significantly decrease prices without compromising R&D investments.OpinionPromoted content
Boosting cross-border collaborations and joint procurement to improve access to new medicines in Europe
Existing cross-border collaborations have shown that pooling resources can facilitate access to new medicines for patients at a fairer price. At the same time, the potential of the EU Joint Procurement Agreement reaches beyond vaccines and treatments for communicable cross-border health threats. VideoPromoted content
Good Off-Label Use Practice of Medicines
Before a drug makes it onto the market it is vigorously tested and needs to be authorized, either by a national competent authority or EMA, the European Medicines Agency. All the information on when a medicinal product can and cannot...
French pilot project may cast new light on access to medical cannabis
A landmark experimentation recently authorised in France can foster patient access to medicinal cannabis in the country and become a role model for Europe.
Early stakeholder dialogues crucial for success of rare orphan medicines
Early dialogue between stakeholders is crucial for the effective development and success of rare orphan drugs, used to treat patients with rare diseases, Anna Bucsics, project adviser at the mechanism of coordinated access to orphan medicinal products (MoCA), told EURACTIV in an interview.
COVID-19 pandemic hinders access to care for patients with rare diseases
Nine out of ten people living with rare diseases across Europe have been negatively impacted by the coronavirus pandemic, including three out of ten who said that this has caused “life-threatening” disruption, according to a recent study by EURORDIS-Rare Diseases Europe.
Call for action over medicine shortages exacerbated by COVID-19 outbreak
Stakeholders across the EU are calling for action on medicine shortages, which they say pose severe threats to patient outcomes, patient safety and patient care. A new report released on Monday (27 April) hopes to help plug the gap.
Health Commissioner unveils roadmap for EU cancer plan
The Commission will kick-off the discussion on the 'Europe's beating cancer plan' next 4 February on the occasion of the world cancer day, while the communication and action plan itself is expected towards the end of 2020, Health Commissioner Stella Kyriakides announced.
EU should adopt German standards on medical cannabis, campaigners say
Germany's regulatory approach to medical cannabis is good practice and should be replicated across Europe, according to newly-born European Medicinal Cannabis Association (EUMCA).
Czech drug policy shifts toward patients with rare diseases
The Czech government has launched a legislative initiative to improve access to most modern medications and rare disease drugs, Health Minister Adam Vojtěch told EURACTIV in an interview, adding that patients are involved in the decision-making process at a very early stage, including in drafting the law.
Investment in digital health and access to drugs at the core of Austrian Presidency
Austria’s EU Presidency will focus on “strong” investment in digital health as well as on regulatory issues when it comes to access to medicines, Dr Clemens Martin Auer told EURACTIV.com in an interview. Dr Clemens Martin Auer is the president of the...
Africa takes steps to make medicine more affordable
Faced with the numerous difficulties of access to medicine in Africa, African states want to organise the market to increase local production, which currently accounts for 3% of world output.